Single dose oral meloxicam for acute postoperative pain in adults
- PMID: 19821429
- PMCID: PMC4175538
- DOI: 10.1002/14651858.CD007552.pub2
Single dose oral meloxicam for acute postoperative pain in adults
Abstract
Background: Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) used mainly in treating pain associated with arthritis. The usual oral dose for osteoarthritis is 15 mg daily, but lower doses of 7.5 mg are advised in older patients. This review sought to evaluate the efficacy and safety of oral meloxicam in acute postoperative pain, using clinical studies of patients with established pain, and with outcomes measured primarily over 6 hours using standard methods. This type of study has been used for many decades to establish that drugs have analgesic properties.
Objectives: To assess the efficacy of single dose oral meloxicam in acute postoperative pain, and any associated adverse events.
Search strategy: We searched Cochrane CENTRAL (Issue 2, 2009), MEDLINE (June 2009); EMBASE (June 2009); the Oxford Pain Relief Database.
Selection criteria: Randomised, double-blind, placebo-controlled clinical trials of oral meloxicam for relief of acute postoperative pain in adults.
Data collection and analysis: Two review authors independently assessed trial quality and extracted data. We planned to use area under the "pain relief versus time" curve to derive the proportion of participants with meloxicam experiencing least 50% pain relief over 4 to 6 hours, using validated equations; to use number needed to treat to benefit (NNT); the proportion of participants using rescue analgesia over a specified time period; time to use of rescue analgesia; information on adverse events and withdrawals.
Main results: No studies were identified by the searches that examined oral meloxicam in patients with established postoperative pain.
Authors' conclusions: In the absence of evidence of efficacy, at present, for oral meloxicam in acute postoperative pain, its use in this indication is not justified. Because trials clearly demonstrating analgesic efficacy in the most basic of acute pain studies is lacking, use in other indications should be evaluated carefully. Given the large number of available drugs of this and similar classes, there is no urgent research agenda.
Conflict of interest statement
SD, RAM & HJM have received research support from charities, government and industry sources at various times. RAM and HJM have consulted for various pharmaceutical companies. RAM, and HJM have received lecture fees from pharmaceutical companies related to analgesics and other healthcare interventions. Support for this review came from Oxford Pain Research, the NHS Cochrane Collaboration Programme Grant Scheme, and NIHR Biomedical Research Centre Programme.
Update of
References
References to studies excluded from this review
Calvo 2007 {published data only}
-
- Calvo AM, Sakai VT, Giglio FP, Modena KC, Colombini BL, Benetello V, et al. Analgesic and anti‐inflammatory dose‐response relationship of 7.5 and 15 mg meloxicam after lower third molar removal: a double‐blind, randomized, crossover study. International Journal of Oral & Maxillofacial Surgery 2007;36(1):26‐31. [DOI: 10.1016/j.ijom.2006.09.006] - DOI - PubMed
Kurukahvecioglu 2007 {published data only}
-
- Kurukahvecioglu O, Karamercan A, Ege B, Koksal H, Anadol Z, Tezel E, et al. Effect of meloxicam on postoperative pain relief after inguinal hernia repair with local anaesthesia. West Indian Medical Journal 2007;56(6):530‐3. - PubMed
Nekoofar 2003 {published data only}
-
- Nekoofar MH, Sadeghipanah M, Dehpour AR. Evaluation of meloxicam (A cox‐2 inhibitor) for management of postoperative endodontic pain: a double‐blind placebo‐controlled study. Journal of Endodontics 2003;29(10):634‐7. - PubMed
Thompson 2000 {published data only}
-
- Thompson JP, Sharpe P, Kiani S, Owen‐Smith O. Effect of meloxicam on postoperative pain after abdominal hysterectomy. British Journal of Anaesthesia 2000;84(2):151‐4. - PubMed
Yilmaz 2006 {published data only}
-
- Yilmaz I, Sener M, Yavuz H, Yilmazer C, Erkan AN, Cagici CA. Postoperative pain management in clinics of otolaryngology [Kulak burun bogaz kliniginde ameliyat sonrasi agri tedavisi]. Kulak burun boğaz ihtisas dergisi : KBB = Journal of Ear, Nose, and Throat 2006;16(1):1‐6. - PubMed
Additional references
Barden 2004
-
- Barden J, Edwards JE, McQuay HJ, Wiffen PJ. Relative efficacy of oral analgesics after third molar extraction. British Dental Journal 2004;197(7):407‐11. - PubMed
Chen 2008
-
- Chen YF, Jobanputra P, Barton P, Bryan S, Fry‐Smith A, Harris G, et al. Cyclooxygenase‐2 selective non‐steroidal anti‐inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation. Health Technology Assessment 2008; Vol. 12, issue 11:1‐278, iii. [ISSN: 1366‐5278] - PubMed
Clarke 2009
Collins 1997
-
- Collins SL, Moore RA, McQuay HJ. The visual analogue pain intensity scale: what is moderate pain in millimetres?. Pain 1997;72:95‐7. - PubMed
Collins 2001
-
- Collins SL, Edwards J, Moore RA, Smith LA, McQuay HJ. Seeking a simple measure of analgesia for mega‐trials: is a single global assessment good enough?. Pain 2001;91(1‐2):189‐94. - PubMed
Cook 1995
Cooper 1991
-
- Cooper SA. Single‐dose analgesic studies: the upside and downside of assay sensitivity. The Design of Analgesic Clinical Trials. Advances in Pain Research Therapy 1991;18:117‐24.
Davies 1999
-
- Davies NM, Skjodt NM. Clinical pharmacokinetics of meloxicam. A cyclo‐oxygenase‐2 preferential nonsteroidal anti‐inflammatory drug. Clinical Pharmacokinetics 1999;36(2):115‐26. - PubMed
Derry 2008
Derry C 2009
Derry C 2009b
Derry P 2009
Fitzgerald 2001
-
- FitzGerald GA, Patrono C. The coxibs, selective inhibitors of cyclooxygenase‐2. New England Journal of Medicine 2001;345(6):433‐42. - PubMed
Gaskell 2009
Gates 2005
Hawkey 1999
-
- Hawkey CJ. Cox‐2 inhibitors. Lancet 1999;353(9149):307‐14. - PubMed
Jadad 1996a
-
- Jadad AR, Carroll D, Moore RA, McQuay H. Developing a database of published reports of randomised clinical trials in pain research. Pain 1996;66(2‐3):239‐46. - PubMed
Jadad 1996b
-
- Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17:1‐12. - PubMed
L'Abbé 1987
-
- L'Abbé KA, Detsky AS, O'Rourke K. Meta‐analysis in clinical research. Annals of Internal Medicine 1987;107:224‐33. - PubMed
Lloyd 2009
McQuay 2005
Moore 1996
-
- Moore A, McQuay H, Gavaghan D. Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics. Pain 1996;66(2‐3):229‐37. - PubMed
Moore 1997a
Moore 1997b
Moore 1997c
Moore 1998
Moore 2003
-
- Moore RA, Edwards J, Barden J, McQuay HJ. Bandolier's Little Book of Pain. Oxford: Oxford University Press, 2003. [ISBN: 0‐19‐263247‐7]
Moore 2005
Moore 2006
-
- Moore A, McQuay H. Bandolier's Little Book of Making Sense of the Medical Evidence. Oxford: Oxford University Press, 2006. [ISBN: 0‐19‐856604‐2]
Moore 2008
Morris 1995
PACT 2007
-
- Prescription Cost Analysis . England 2007. [ISBN: 978‐1‐84636‐210‐1]
Schoenfeld 1999
-
- Schoenfeld P. Gastrointestinal safety profile of meloxicam: a meta‐analysis and systematic review of randomized controlled trials. The American Journal of Medicine 1999;107(6A):48S‐54S. - PubMed
Toms 2008
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
